Diagnosis and treatment of malignant pancreatic endocrine tumour.
- Author:
Lei WANG
1
;
Yu-Pei ZHAO
;
Chia-I LEE
;
Quan LIAO
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; therapeutic use; Carcinoma, Islet Cell; diagnosis; pathology; therapy; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Gastrectomy; Gastrinoma; diagnosis; pathology; therapy; Glucagonoma; diagnosis; pathology; therapy; Humans; Insulinoma; diagnosis; pathology; therapy; Liver Neoplasms; secondary; therapy; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Pancreas; surgery; Pancreatectomy; Pancreatic Neoplasms; diagnosis; pathology; therapy; Retrospective Studies
- From: Chinese Medical Sciences Journal 2004;19(2):130-133
- CountryChina
- Language:English
-
Abstract:
OBJECTIVETo summarize our experience in the diagnosis and treatment of malignant pancreatic endocrine tumour.
METHODSWe retrospectively reviewed 36 cases of malignant pancreatic endocrine tumours in our hospital from July 1987 to April 2002, and summarized its clinical features.
RESULTSLiver metastasis was the main malignant manifestation of malignant pancreatic endocrine tumours (incidence rate 72.2%). Removals of primary lesion and isolated hepatic metastatic lesion were means of curative therapy. Interventional chemotherapy was an important adjuvant treatment.
CONCLUSIONComprehensive therapy plays an important role in improving the prognosis of malignant pancreatic endocrine tumour.
